Antibiotic prescriptions for COVID-19 patients increased during the BA.5 period

Table 1.

Comparison with patients’ characteristicsbetween BA.1/2 period and BA.5 period in2022.

 

 

Jan-Mar (n=135, BA.1)

Jul-Sep (n=160, BA.4/5)

p value

Age

66.5+-16.0

 

68.7+-19.0

 

0.14

Antibiotics (+)

14.8%(20/135)

 

26.3% (42/160)

 

0.016*

 

Respiratory

 

10.4%(14/135)

16.9% (27/160)

0.14

 

Urinary

 

1.5%(2/135)

 

0.6%(1/160)

0.47

 

Abdomen

 

1.5%(2/135)

 

5.0%(8/160)

0.09

 

Skin

 

0.7%(1/135)

 

1.9%(3/160)

0.4

 

Brain

 

0

 

1.3%(2/160)

0.19

 

Bacteremia

 

0.7%(1/135)

 

0

0.28

 

Unknown

 

0

 

0.6%(1/160)

0.36

Total Mortality

7.9%(10/135)

 

1.7% (2/160)

 

0.008**